Christopher L Farrell

7PUBLICATIONS
13CO-AUTHORS
PharmacogenomicsNanotoxicology, health and safetyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Toxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 27, 2026
Managing Secondary Findings from Germline Pharmacogenomic Testing.

|Jul 15, 2026
Metrics Used for the Evaluation of Chatbots Providing Cancer Genetic Risk Assessment and Education: Systematic Review.

|Jan 27, 2026
Metabolic Signatures of Breast Cancer Subtypes and the Metabolic Impact of Chemotherapy.

Aubrey Mattingly, Zoe Vickery, Alex Fiorentino

|Dec 27, 2024
Exploring the Therapeutic Potential for Breast Cancer of Phytochemicals and Secondary Metabolites in Marjoram, Thyme, and Persimmon.

Aubrey Mattingly, Zoe Vickery, Diana Ivankovic

|Nov 27, 2024
Gene Variant Frequencies of IDO1, IDO2, TDO, and KMO in Substance Use Disorder Cohorts.

Lindsey Contella, Christopher L Farrell, Luigi Boccuto

|Nov 26, 2024
Impact of Substance Use Disorder on Tryptophan Metabolism Through the Kynurenine Pathway: A Narrative Review.

Lindsey Contella, Christopher L Farrell, Luigi Boccuto

Pageof 2

Frequent Collaborators

4 joint publications

Luigi Boccuto

2 joint publications

Lindsey Contella

2 joint publications

Zoe Vickery

2 joint publications

Diana Ivankovic